Abstract: A vehicle is received in a stationary controlled area of a controlled testing environment. Simulation inputs corresponding to a simulated scene are generated and transmitted to the vehicle. The vehicle applies torque in response. A vehicle control mechanism of the controlled testing environment, such as a chassis dynamometer, a motorized treadmill, or a lift, keeps the vehicle within the stationary controlled area during the test despite the torque applied by the vehicle. A path of the vehicle within the simulated scene is determined based on the applied torque, based upon which the vehicle's navigation system is calibrated.

Abstract: A vehicle is received in a stationary controlled area of a controlled testing environment. Simulation inputs corresponding to a simulated scene are generated and transmitted to the vehicle. The vehicle applies torque in response. A vehicle control mechanism of the controlled testing environment, such as a chassis dynamometer, a motorized treadmill, or a lift, keeps the vehicle within the stationary controlled area during the test despite the torque applied by the vehicle. A path of the vehicle within the simulated scene is determined based on the applied torque, based upon which the vehicle's navigation system is calibrated.

Abstract: A vehicle is received in a stationary controlled area of a controlled testing environment. Simulation inputs corresponding to a simulated scene are generated and transmitted to the vehicle. The vehicle applies torque in response. A vehicle control mechanism of the controlled testing environment, such as a chassis dynamometer, a motorized treadmill, or a lift, keeps the vehicle within the stationary controlled area during the test despite the torque applied by the vehicle. A path of the vehicle within the simulated scene is determined based on the applied torque, based upon which the vehicle's navigation system is calibrated.

Abstract: A vehicle is received in a stationary controlled area of a controlled testing environment. Simulation inputs corresponding to a simulated scene are generated and transmitted to the vehicle. The vehicle applies torque in response. A vehicle control mechanism of the controlled testing environment, such as a chassis dynamometer, a motorized treadmill, or a lift, keeps the vehicle within the stationary controlled area during the test despite the torque applied by the vehicle. A path of the vehicle within the simulated scene is determined based on the applied torque, based upon which the vehicle's navigation system is calibrated.

Abstract: A vehicle is received in a stationary controlled area of a controlled testing environment. Simulation inputs corresponding to a simulated scene are generated and transmitted to the vehicle. The vehicle applies torque in response. A vehicle control mechanism of the controlled testing environment, such as a chassis dynamometer, a motorized treadmill, or a lift, keeps the vehicle within the stationary controlled area during the test despite the torque applied by the vehicle. A path of the vehicle within the simulated scene is determined based on the applied torque, based upon which the vehicle's navigation system is calibrated.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of th4e analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g., insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.

Abstract: Some embodiments disclosed provide a method for determining whether to activate a notification in an analyte monitoring system. The method includes receiving a projection time period, determining a measurement of a concentration of an analyte in a sample of bodily fluid, determining whether the measurement of the concentration of the analyte is within a specified range, and determining whether to activate the notification by evaluating whether the concentration of the analyte is projected to be within the specified range at a future time during the projection time period, if the measurement of the concentration of the analyte is not within the specified range.

Abstract: Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment drug (e.g. insulin or glucose) and provide glycemic control. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte.